David W Salzman
机构: Yale University, Biogen, MiraDx, Gatehouse Bio
每年引用次数
引用次数
引用: 764
H-指数: 9
I10-指数 : 9
出版物: 27
The 5' terminal uracil of let-7a is critical for the recruitment of mRNA to Argonaute2.
Kristin M. Felice , David W. Salzman , Jonathan Shubert-Coleman , Kevin P. Jensen
Biochemical Journal 422 ( 2) 329 -341
24
2009
Germ-line biomarkers disrupting microRNA regulatory pathways to predict toxicity and response to anti-PD-1 and anti-PD-L1 therapies.
Joanne B. Weidhaas , Donatello Telesca , Anusha Kalbasi , David Salzman
Journal of Clinical Oncology 35 3040 -3040
4
2017
Estrogen withdrawal, breast cell transformation, and multiple breast cancer risk in women with the KRAS-variant.
Joanne B. Weidhaas , Terri Patricia McVeigh , Song Yi Jung , David Salzman
Journal of Clinical Oncology 33 ( 15_suppl) e12541 -e12541
2015
A germline microRNA-based biomarker signature of immune-associated toxicity to anti-PD1/PDL1 therapy.
Joanne B. Weidhaas , Aaron Wolfe Scheffler , David Salzman , Anusha Kalbasi
Journal of Clinical Oncology 37 ( 8_suppl) 96 -96
2019
Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9.
Daniel Gautheret , Joseph Taube , Sendurai Mani , Gaetano Santulli
Non-Coding RNA 2 ( 4) 10 -10
2016
The Non-Coding RNA Journal Club: Highlights on Recent Papers—4
Daniel Gautheret , Joseph Taube , Sendurai Mani , Gaetano Santulli
Non-Coding RNA 2 ( 3) 9
2016
ASO Lowering of SOD1 Markedly Extends Survival and Reverses Muscle Denervation in SOD1 ALS Rodent Models
Timothy Miller , Alex McCampbell , Tracy Cole , Amy Wegener
ANNALS OF NEUROLOGY 82 S103 -S104
2017
Small rna predictors for huntington's disease
David Salzman
2024
Methods for identifying and using small rna predictors
David Salzman
2021
Small rna predictors for huntington's disease
David Salzman
2020
Estrogen withdrawal and breast cancer development in the presence of the KRAS-variant
Song-Yi Jung , David Salzman , Joanne B Weidhaas
Cancer Research 75 ( 15_Supplement) 2872 -2872
2015
miRNAs in the spotlight: Making 'silent' mutations speak up
David W Salzman , Joanne B Weidhaas
Nature Medicine 17 ( 8) 934 -935
9
2011
A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.
Jemima J Dorairaj , David W Salzman , Deirdre Wall , Tiffany Rounds
BMC Cancer 14 ( 1) 421 -421
8
2014
Estrogen withdrawal, increased breast cancer risk and the KRAS-variant
Terri P McVeigh , Song-Yi Jung , Michael J Kerin , David W Salzman
Cell Cycle 14 ( 13) 2091 -2099
9
2015
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
Alex McCampbell , Tracy Cole , Amy J Wegener , Giulio S Tomassy
Journal of Clinical Investigation 128 ( 8) 3558 -3567
78
2018
Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers—4. Non-Coding RNA
Daniel Gautheret , Joseph H Taube , Sendurai A Mani , Gaetano Santulli
Identification of Biomarkers for Early-Detection and Monitoring of Huntington Disease
David W Salzman , Joli Bregu , Nathan S Ray , Richard H Myers
NEUROTHERAPEUTICS 15 ( 4) 1213 -1214
2018
Small rna disease classifiers
David W Salzman , Alan P Salzman , Neal C Foster , Terran Melconian
1
2023
Small rna predictors for alzheimer's disease
David W Salzman , Alan P Salzman , Neal C Foster
2021
The regulation of microRNA activity
David W Salzman
University of Connecticut
2009